- QTRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SC 13D Filing
Quanterix (QTRX) SC 13DQuanterix / Akoya Biosciences ownership change
Filed: 16 Jan 25, 9:29pm
Exhibit 99.1
SCHEDULE A
Directors and Executive Officers of Akoya Biosciences, Inc.
Name | Position |
Brian McKelligon | President, Chief Executive Officer and Director |
Johnny Elk | Chief Financial Officer |
Jennifer Kamocsay | General Counsel |
Pascal Bamford | Chief Clinical Officer |
Niro Ramachandran | Chief Business Officer |
Robert G. Shepler | Director, Chairman of the Board |
Thomas Raffin | Director |
Thomas P. Schnettler | Director |
Scott Mendel | Director |
Matthew Winkler | Director |
Myla Lai-Goldman | Director |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.